Towne TG, Murray A (2014) Cisplatin. Encyclopedia of toxicology, 3rd edn. Academic Press, pp 973–975

Google Scholar 

Singh R, Upadhayay A, Kale MK (2018) Effect of liposomes as a carrier on pharmacokinetics of cisplatin. Res J Pharm Technol 11:5073–5077

Google Scholar 

Mei Y (2021) Review of the toxicological mechanism of anticancer drug cisplatin. In: AIP conference proceedings.

Oun R, Moussa YE, Wheate NJ (2018) The side effects of platinum-based chemotherapy drugs: a review for chemists. Dalton Trans 47:6645–6653

CAS  PubMed  Google Scholar 

Zraik IM, Heß-Busch Y (2021) Management of chemotherapy side effects and their long-term sequelae. Urologe 60:862–871

Google Scholar 

Hassan H (2022) The role of probiotics in people with cancer. Probiotics for human nutrition in health and disease. Academic Press, pp 537–556

Google Scholar 

Mondlane ER, Abreu-Mendes P, Martins D, Cruz R, Mendes F (2021) The role of immunotherapy in advanced renal cell carcinoma. Int Braz J Urol 47:1228–1242

PubMed  PubMed Central  Google Scholar 

Firkins J, Hansen L, Driessnack M, Dieckmann N (2020) Quality of life in “chronic” cancer survivors: a meta-analysis. J Cancer Surviv 14:504–517

PubMed  Google Scholar 

Gegechkori N, Haines L, Lin JJ (2017) Long-term and latent side effects of specific cancer types. Med Clin North Am 101:1053–1073

PubMed  PubMed Central  Google Scholar 

Orel V, Zabolotny M, Rykhalskyi O, Shevchenko A, Yashchuck V, Losytskyi M, Orel VB (2020) Fluorescence properties of doxorubicin-loaded iron oxide nanoparticles. In: Springer proceedings in physics. p 401–409

Mitsui Y, Sadahira T, Araki M, Maruyama Y, Wada K, Tanimoto R, Kobayashi Y, Watanabe M, Watanabe T, Nasu Y (2019) Loss of psoas major muscle volume during systemic chemotherapy is related to worse prognosis in testicular cancer. Jpn J Clin Oncol 49:183–189

PubMed  Google Scholar 

Yuan Q, Hu J, Yuan F, An J (2023) Predictive role of pretreatment skeletal muscle mass index for long-term survival of bladder cancer patients: a meta-analysis. PLoS ONE 18:e0288077

CAS  PubMed  PubMed Central  Google Scholar 

Sakai H, Sagara A, Arakawa K, Sugiyama R, Hirosaki A, Takase K, Jo A, Sato K, Chiba Y, Yamazaki M, Matoba M, Narita M (2014) Mechanisms of cisplatin-induced muscle atrophy. Toxicol Appl Pharmacol 278:190–199

CAS  PubMed  Google Scholar 

Sakai H, Asami M, Naito H, Kitora S, Suzuki Y, Miyauchi Y, Tachinooka R, Yoshida S, Kon R, Ikarashi N, Chiba Y, Kamei J (2021) Exogenous insulin-like growth factor 1 attenuates cisplatin-induced muscle atrophy in mice. J Cachexia Sarcopenia Muscle 12:1570–1581

PubMed  PubMed Central  Google Scholar 

Sakai H, Ikeno Y, Tsukimura Y, Inomata M, Suzuki Y, Kon R, Ikarashi N, Chiba Y, Yamada T, Kamei J (2020) Upregulation of ubiquitinated proteins and their degradation pathway in muscle atrophy induced by cisplatin in mice. Toxicol Appl Pharmacol 403:115165

CAS  PubMed  Google Scholar 

Sato K, Satoshi Y, Miyauchi Y, Sato F, Kon R, Ikarashi N, Chiba Y, Hosoe T, Sakai H (2024) Downregulation of PGC-1alpha during cisplatin-induced muscle atrophy in murine skeletal muscle. Biochim Biophys Acta Mol Basis Dis 1870:166877

CAS  PubMed  Google Scholar 

Henderson FM, Cross AJ, Baraniak AR (2019) ‘A new normal with chemobrain’: Experiences of the impact of chemotherapy-related cognitive deficits in long-term breast cancer survivors. Health Psychol Open 6:2055102919832234

PubMed  PubMed Central  Google Scholar 

Ongnok B, Chattipakorn N, Chattipakorn SC (2020) Doxorubicin and cisplatin induced cognitive impairment: the possible mechanisms and interventions. Exp Neurol 324:113118

CAS  PubMed  Google Scholar 

Matsos A, Johnston IN (2019) Chemotherapy-induced cognitive impairments: a systematic review of the animal literature. Neurosci Biobehav Rev 102:382–399

CAS  PubMed  Google Scholar 

Umfress A, Speed HE, Tan C, Ramezani S, Birnbaum S, Brekken RA, Sun X, Plattner F, Powell CM, Bibb JA (2021) Neuropathological effects of chemotherapeutic drugs. ACS Chem Neurosci 12:3038–3048

CAS  PubMed  Google Scholar 

Nguyen LD, Ehrlich BE (2020) Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases. EMBO Mol Med 12:e12075

CAS  PubMed  PubMed Central  Google Scholar 

Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Bostrom EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Hojlund K, Gygi SP, Spiegelman BM (2012) A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481:463–468

PubMed  PubMed Central  Google Scholar 

Zhang H, Wu X, Liang J, Kirberger M, Chen N (2022) Irisin, an exercise-induced bioactive peptide beneficial for health promotion during aging process. Ageing Res Rev 80:101680

CAS  PubMed  Google Scholar 

Bellettini-Santos T, Batista-Silva H, Marcolongo-Pereira C, Quintela-Castro FCA, Barcelos RM, Chiepe K, Rossoni JV Jr, Passamani-Ambrosio R, da Silva BS, Chiarelli-Neto O, Garcez ML (2023) Move your body toward healthy aging: potential neuroprotective mechanisms of irisin in Alzheimer’s disease. Int J Mol Sci 24:12440

CAS  PubMed  PubMed Central  Google Scholar 

Chen K, Wang K, Wang T (2022) Protective effect of irisin against Alzheimer’s disease. Front Psychiatry 13:967683

PubMed  PubMed Central  Google Scholar 

Kobilo T, Guerrieri D, Zhang Y, Collica SC, Becker KG, van Praag H (2014) AMPK agonist AICAR improves cognition and motor coordination in young and aged mice. Learn Mem 21:119–126

CAS  PubMed  PubMed Central  Google Scholar 

Sakai H, Zhou Y, Miyauchi Y, Suzuki Y, Ikeno Y, Kon R, Ikarashi N, Chiba Y, Hosoe T, Kamei J (2022) Increased 20S proteasome expression and the effect of bortezomib during cisplatin-induced muscle atrophy. Biol Pharm Bull 45:910–918

CAS  PubMed  Google Scholar 

Sakai H, Kimura M, Isa Y, Yabe S, Maruyama A, Tsuruno Y, Kai Y, Sato F, Yumoto T, Chiba Y, Narita M (2017) Effect of acute treadmill exercise on cisplatin-induced muscle atrophy in the mouse. Pflugers Arch 469:1495–1505

CAS  PubMed  Google Scholar 

Sakai H, Kimura M, Tsukimura Y, Yabe S, Isa Y, Kai Y, Sato F, Kon R, Ikarashi N, Narita M, Chiba Y, Kamei J (2019) Dexamethasone exacerbates cisplatin-induced muscle atrophy. Clin Exp Pharmacol Physiol 46:19–28

CAS  PubMed  Google Scholar 

Anderson-Hanley C, Sherman ML, Riggs R, Agocha VB, Compas BE (2003) Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc 9:967–982

PubMed  Google Scholar 

Squillace S, Niehoff ML, Doyle TM, Green M, Esposito E, Cuzzocrea S, Arnatt CK, Spiegel S, Farr SA, Salvemini D (2022) Sphingosine-1-phosphate receptor 1 activation in the central nervous system drives cisplatin-induced cognitive impairment. J Clin Invest 132:e157738

CAS  PubMed  PubMed Central  Google Scholar 

Ferraro E, Giammarioli AM, Chiandotto S, Spoletini I, Rosano G (2014) Exercise-induced skeletal muscle remodeling and metabolic adaptation: redox signaling and role of autophagy. Antioxid Redox Signal 21:154–176

CAS  PubMed  PubMed Central  Google Scholar 

Grahame Hardie D (2016) Regulation of AMP-activated protein kinase by natural and synthetic activators. Acta Pharm Sin B 6:1–19

PubMed  Google Scholar 

Jager S, Handschin C, St-Pierre J, Spiegelman BM (2007) AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci U S A 104:12017–12022

PubMed  PubMed Central  Google Scholar 

Kim E, Kim H, Jedrychowski MP, Bakiasi G, Park J, Kruskop J, Choi Y, Kwak SS, Quinti L, Kim DY, Wrann CD, Spiegelman BM, Tanzi RE, Choi SH (2023) Irisin reduces amyloid-beta by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signaling. Neuron 111(3619–3633):e3618

Google Scholar 

Madhu LN, Somayaji Y, Shetty AK (2022) Promise of irisin to attenuate cognitive dysfunction in aging and Alzheimer’s disease. Ageing Res Rev 78:101637

CAS  PubMed  PubMed Central  Google Scholar 

Zhang F, Hou G, Hou G, Wang C, Shi B, Zheng Y (2021) Serum irisin as a potential biomarker for cognitive decline in vascular dementia. Front Neurol 12:755046

PubMed  PubMed Central  Google Scholar